Could a simple pill replace insulin shots for tiny preemies?
NCT ID NCT05687500
Summary
This study is testing if a pill called glibenclamide can safely control high blood sugar in very premature, low-birth-weight babies. It aims to offer an easier alternative to the current standard treatment, which involves tricky-to-manage insulin injections that carry a risk of dangerously low blood sugar. The trial will enroll 35 infants to see if the oral treatment works and is safe for this fragile group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Necker - Enfants malades
RECRUITINGParis, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.